DexCom Inc (DXCM)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
DexCom Inc's days of sales outstanding (DSO) information is not available in the provided data for the period spanning from March 31, 2020, to December 31, 2024. DSO is a crucial metric that measures the average number of days a company takes to collect revenue after a sale has been made. A low DSO value indicates that the company is efficient in collecting payments from its customers, whereas a high DSO value may signify potential issues with accounts receivable management or difficulties in collecting payments promptly. Without specific DSO figures, it is challenging to assess DexCom Inc's efficiency in converting sales into cash inflows over time. A detailed analysis of DSO trends would have provided valuable insights into the company's revenue collection efficiency and overall financial health.
Peer comparison
Dec 31, 2024
See also:
DexCom Inc Average Receivable Collection Period (Quarterly Data)